Fundraising Fox

Forty Seven Inc

acquired by Gilead

Palo Alto, US · Founded 2014 · 14,911 employees on LinkedIn · 3 known investors

Find your way into Forty Seven Inc

Acquired by Gilead Sciences March 2020 · terms undisclosed

Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries. The company combines scientific research with global partnerships to expand patient access to treatments.

BiotechHealthtechMedical Devices

Founders & leadership

Forty Seven Inc was founded in 2014 by Ravindra Majeti and Irving Weissman.

RM
Ravindra MajetiCo-founder
IW
Irving WeissmanCo-founder
EJ
Eric JensenExecutive

Board

CSChristopher Schaepe
Christopher Schaepein𝕏Board directorAngel
JBJeffrey Bird
Jeffrey BirdinBoard directorManaging Director at Bluebird Ventures
DH
Dennis HennerBoard director
JMJonathan MacQuitty
Jonathan MacQuittyinBoard directorPartner at Lightspeed Venture Partners

Investors · 3

Bluebird VenturesPalo Altovia Jeffrey Bird · inferred
Lightspeed Venture PartnersMenlo Park · $1.7M – $87Mvia Jonathan MacQuitty · board
Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements

$109.1M disclosed across 2 rounds · 2015–2017

▶$75MraisedOct 2017 · 32 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ravindra MajetiDirector
  • Mark A. McCamishExecutive Officer, Director
  • Chris SchaepeDirector
  • Irving WeissmanDirector
  • Dennis HennerDirector
  • Jeffrey BirdDirector
  • Jonathan MacQuittyDirector
Offering amount
$75M
Amount sold
$75M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$34.1MraisedMar 2016 · 32 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher SchaepeDirector
  • Jeffrey BirdDirector
  • Dennis HennerDirector
  • Ravindra MajetiDirector
  • Eric JensenExecutive Officer
  • Irving WeissmanDirector
  • Jonathan MacQuittyExecutive Officer, Director
Offering amount
$74.8M
Amount sold
$34.1M
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Forty Seven Inc went on to found or lead other companies.

Kristine BallBoard MemberFounded Soteria Biotherapeutics +1Roy MauteDirector of Translational ResearchFounded Pheast Therapeutics

In the news

Startup Forty Seven Inc Completes $75M Series B Financing - Research & Development Worldrdworldonline.com · Oct 2017Forty Seven Inc. Completes $75 Million Series B Financingprnewswire.com · Oct 2017Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs | Fierce Biotechfiercebiotech.com · Feb 2016

Frequently asked questions

What does Forty Seven Inc do?
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries. The company combines scientific research with global partnerships to expand patient access to treatments.
Who founded Forty Seven Inc?
Forty Seven Inc was founded by Ravindra Majeti, Irving Weissman in 2014.
Who are Forty Seven Inc's investors?
Forty Seven Inc's investors include Bluebird Ventures, Lightspeed Venture Partners, Sofinnova Ventures.
How much funding has Forty Seven Inc raised?
Forty Seven Inc has disclosed $109.1M raised across 2 rounds.
Who acquired Forty Seven Inc?
Forty Seven Inc was acquired by Gilead.
Where is Forty Seven Inc headquartered?
Forty Seven Inc is headquartered in Palo Alto, US.